| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Michael R Charlton | |
| Kymberly D S Watt | |||
| P433 | issue | 1 | |
| P921 | main subject | metabolic syndrome | Q657193 |
| liver transplantation | Q1368191 | ||
| P304 | page(s) | 199-206 | |
| P577 | publication date | 2010-03-31 | |
| P1433 | published in | Journal of Hepatology | Q15724402 |
| P1476 | title | Metabolic syndrome and liver transplantation: a review and guide to management | |
| P478 | volume | 53 |
| Q37807577 | Advances in Hepatobiliary Pathology: Update for 2010 |
| Q47384747 | Alcohol Relapse After Liver Transplantation for Alcoholic Cirrhosis-Impact on Liver Graft and Patient Survival: A Meta-analysis |
| Q39706131 | Alcohol Use after Liver Transplantation is Independent of Liver Disease Etiology |
| Q28074308 | Cardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective study |
| Q38103630 | Cardiovascular risk, atherosclerosis and metabolic syndrome after liver transplantation: a mini review |
| Q49812544 | Changes in dietary patterns and body composition within 12 months of liver transplantation. |
| Q37284598 | Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report |
| Q46148440 | Early development of metabolic syndrome in patients subjected to lung transplantation |
| Q50599104 | Effect of pretransplant diabetes on short-term outcomes after liver transplantation: a national cohort study |
| Q87644212 | Evaluation for liver transplantation in adults: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation |
| Q90704957 | Everolimus vs Mycophenolate Mofetil in Combination With Tacrolimus: A Propensity Score-matched Analysis in Liver Transplantation |
| Q98288224 | Expert consensus on management of metabolic disease in Chinese liver transplant recipients |
| Q26822887 | From immunosuppression to tolerance |
| Q38192013 | Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation. |
| Q38061619 | Influence of age and gender before and after liver transplantation |
| Q50454323 | Is a flavonoid-rich diet with steamer cooking safe during calcineurin inhibitors therapy? |
| Q38028441 | Is liver transplantation a risk factor for cardiovascular disease? A meta-analysis of observational studies |
| Q34499022 | Liver transplantation and non-alcoholic fatty liver disease |
| Q36220176 | Liver transplantation in adults: Choosing the appropriate timing |
| Q37203525 | Liver transplantation in alcoholic liver disease current status and controversies |
| Q39295671 | Liver transplantation: post-transplant management |
| Q34646976 | Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation |
| Q36399571 | Long-term medical management of the liver transplant recipient: what the primary care physician needs to know |
| Q46390308 | Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation. |
| Q38002368 | Long-term outcome after liver transplantation |
| Q49850570 | Long-term outcomes of patients undergoing simultaneous Liver Transplantation and Sleeve Gastrectomy. |
| Q92458712 | Management of metabolic syndrome and cardiovascular risk after liver transplantation |
| Q38063169 | Management of post-transplant diabetes |
| Q37421526 | Medical Management of Metabolic Complications of Liver Transplant Recipients |
| Q60640976 | Metabolic Syndrome in Transplant Patients: An Academic or a Health Burden? |
| Q28082243 | Metabolic and cardiovascular complications in the liver transplant recipient |
| Q28073134 | Metabolic complications in liver transplant recipients |
| Q38682089 | Metabolic syndrome and non-alcoholic fatty liver disease after liver or kidney transplantation |
| Q51564249 | Mortality in nonalcoholic fatty liver disease: clues from the Cremona study. |
| Q30248646 | NAFLD and liver transplantation: Current burden and expected challenges |
| Q26751404 | Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant |
| Q52584505 | Nonalcoholic fatty liver disease and liver transplantation - Where do we stand? |
| Q38191466 | Overweight in liver transplant recipients. |
| Q28728208 | Posttransplant metabolic syndrome in children and adolescents after liver transplantation: a systematic review |
| Q40400192 | Prediabetes in Pediatric Recipients of Liver Transplant: Mechanism and Risk Factors |
| Q50635492 | Prevalence and risk factors of obesity, hypertension, dyslipidemia and diabetes mellitus before and after adult living donor liver transplantation |
| Q33577480 | Prevalence of Metabolic Syndrome in Liver Transplant Recipients in Iran |
| Q41226760 | Prevalence of hypertension after living-donor liver transplantation: a prospective study |
| Q33887123 | Pro-atherosclerotic markers and cardiovascular risk factors one year after liver transplantation |
| Q53095314 | Prospective evaluation of metabolic syndrome and its components among long-term liver recipients. |
| Q48232083 | Reducing the load: the evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation |
| Q38668209 | Risk factors of metabolic syndrome after liver transplantation. |
| Q45368411 | Severe rhabdomyolysis due to rosuvastatin in a liver transplant subject with human immunodeficiency virus and immunosuppressive therapy-related dyslipidemia |
| Q38754960 | Simultaneous living donor liver transplant with sleeve gastrectomy for metabolic syndrome and NASH-related ESLD-First report from India. |
| Q94570291 | Spotlight on Impactful Research: Long-Term Calcineurin Inhibitor Therapy and Brain Function in Patients After Liver Transplantation |
| Q104472223 | Steroid-Free Versus Steroid-Containing Immunosuppression for Liver Transplant Recipients |
| Q48269348 | The Role of Bariatric Surgery in Abdominal Organ Transplantation-the Next Big Challenge? |
| Q99711234 | Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational Study |
| Q35060274 | Weight gain, overweight and obesity in solid organ transplantation--a study protocol for a systematic literature review. |
Search more.